Halozyme Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $91.3M
Liabilities Breakdown FY2010
Total Liabilities: $71.0M
Asset Breakdown
Total Assets: $91.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $82.8M | 90.6% |
| Accounts Receivable | $2.3M | 2.5% |
| Inventory | $193.4K | 0.2% |
| Property, Plant & Equipment | $1.8M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.2M | 4.6% |
Liabilities Breakdown
Total Liabilities: $71.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 5.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $67.2M | 94.6% |